INTRODUCTION.
Several animal-and plant-interacting Gram-negative bacteria possess the socalled type III secretion system or TTSS, which functions to inject proteins (or 'effectors') directly into eukaryotic cells [1] . TTSS effectors play important roles in a variety of host-microbe interactions including Rhizobium-mediated root nodulation, plant hypersensitivity reactions, and in animals, modulating immune responses. The pathogenic yersiniae (Yersinia pestis, Y. pseudotuberculosis, and Y. enterocolitica) inject five TTSS effectors all of which are required for full virulence in the mouse model. As might be expected since they function within host cells, Yersinia's TTSS effectors possess clear eukaryotic-like protein domains or motifs. One of these effectors, the Yersinia protein kinase A (YpkA), contains the canonical 11 subdomains (I-XI) characteristic of eukaryotic ser/thr protein kinases with a highly conserved catalytic core sequence. In addition to the amino-terminally located kinase domain, YpkA, also contains in its carboxyl-terminal region sequences that resemble eukaryotic RhoA-binding domains.
RESULTS AND DISCUSSION.
We have previously shown by flow cytometry that the expression of TTSS effectors increase in individual bacteria following contact with cultured macrophage-like cells [2] . In a cell culture infection assay, a strain of Y. pseudotuberculosis expressing an enzymatic inactive variant of YpkA (YpkA D270A ) was greatly attenuated in its ability to proliferate compared to the wild-type strain when incubated with eukaryotic cells. To identify eukaryotic proteins that physically interact with YpkA, we performed yeast two-hybrid screening using YpkA's kinase domain as bait. In a library prepared from human spleen, we discovered that the calcium-and integrin-binding (CIB) protein interacts with YpkA and have gone on to show that the YpkA-CIB association occurs in an in vitro protein interaction assay. We are currently testing whether CIB (a.k.a. 'calmyrin'), a peripheral membrane protein [3, 4] in fact localizes YpkA to the inner face of the plasma membrane following its injection into eukaryotic cells [5] . We have also found that YpkA's kinase activity was not required in a cell morphology assay in which YpkA induces HeLa cells to undergo retraction. Instead the carboxyl-terminal region of YpkA, which contains sequence similarity to eukaryotic RhoA-binding domains, is required for YpkA-mediated morphological changes of eukaryotic cells [5] . YpkA does indeed interact with RhoA (and Rac but not Cdc42) in protein interaction assays, but interestingly, unlike eukaryotic RhoA-binding proteins, with which it shares sequence similarity, YpkA binds both the activated GTP-bound form of RhoA as well as inactive GDP-bound RhoA.
Although the significance of CIB and RhoA targeting by YpkA, both in terms of the cell biology and, in a larger sense, pathogenesis, is currently unclear, we believe that characterizing these events will eventually lead us to an understanding of how this virulence factor promotes bacterial proliferation vis-à-vis the eukaryotic host cell.
